Murray david andersson borje (25 risultati)
Lingua: Inglese
Editore: Kluwer Academic, Boston 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Tiber Books, Cockeysville, MD, U.S.A.Tiber Books
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Molto buono
EUR 22,60
EUR 4,82 spedizioneSpedito in U.S.A.Quantità: 1 disponibili
Hardcover. Condizione: Very Good. . . . . 8vo, hardcover. No dj. Vg condition. Prev. owner's name-labels very neatly removed from endpaper, contents bright, crisp & clean, unread. xx, 380 p.
Lingua: Inglese
Editore: Springer 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Better World Books Ltd, Dunfermline, Regno UnitoBetter World Books Ltd
Contatta il venditoreVenditore con 5 stelleCondizione: Usato - Molto buono
EUR 27,83
EUR 5,79 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Condizione: Very Good. 2002nd Edition. Former library copy. Pages intact with possible writing/highlighting. Binding strong with minor wear. Dust jackets/supplements may not be included. Includes library markings. Stock photo provided. Product includes identifying sticker. Better World Books: Buy Books. Do Good.
Lingua: Inglese
Editore: Springer 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 115,62
EUR 13,88 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In.
Lingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: Ria Christie Collections, Uxbridge, Regno UnitoRia Christie Collections
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 115,62
EUR 13,88 spedizioneSpedito da Regno Unito a U.S.A.Quantità: Più di 20 disponibili
Condizione: New. In.
Lingua: Inglese
Editore: Springer 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.Romtrade Corp.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 140,21
Spedizione gratuitaSpedito in U.S.A.Quantità: 1 disponibili
Condizione: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.
Lingua: Inglese
Editore: Springer 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Basi6 International, Irving, TX, U.S.A.Basi6 International
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 140,21
Spedizione gratuitaSpedito in U.S.A.Quantità: 1 disponibili
Condizione: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service.
Lingua: Inglese
Editore: Springer US 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 92,27
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Condizione: New.
Lingua: Inglese
Editore: Springer US 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: moluna, Greven, Germaniamoluna
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 92,27
EUR 48,99 spedizioneSpedito da Germania a U.S.A.Quantità: Più di 20 disponibili
Gebunden. Condizione: New.
Lingua: Inglese
Editore: Kluwer Academic Publishers 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Kennys Bookshop and Art Galleries Ltd., Galway, GY, IrlandaKennys Bookshop and Art Galleries Ltd.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 131,63
EUR 10,50 spedizioneSpedito da Irlanda a U.S.A.Quantità: 15 disponibili
Condizione: New. Reviews clinically relevant aspects of the pharmacokinetics of commonly used anticancer agents as well as mechanisms of cellular/experimental resistance to such agents. Editor(s): Andersson, Borje; Murray, David. Series: Cancer Treatment and Research. Num Pages: 400 pages, biography. BIC Classification: MJCL2. C…ategory: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 28. Weight in Grams: 777. . 2002. Hardback. . . . .
Lingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: Books Puddle, New York, NY, U.S.A.Books Puddle
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 165,86
EUR 3,50 spedizioneSpedito in U.S.A.Quantità: 4 disponibili
Condizione: New. pp. 404.
Lingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 157,00
EUR 14,48 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Paperback. Condizione: Brand New. reprint edition. 400 pages. 9.25x6.10x0.91 inches. In Stock.
Lingua: Inglese
Editore: Springer US 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 95,70
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. Clinically Relevant Resistance in Cancer Chemotherapy | David Murray (u. a.) | Taschenbuch | xx | Englisch | 2002 | Springer US | EAN 9781402072000 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: pre…igu.
Altre immaginiLingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: preigu, Osnabrück, Germaniapreigu
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 95,70
EUR 70,00 spedizioneSpedito da Germania a U.S.A.Quantità: 5 disponibili
Taschenbuch. Condizione: Neu. Clinically Relevant Resistance in Cancer Chemotherapy | David Murray (u. a.) | Taschenbuch | xx | Englisch | 2012 | Springer | EAN 9781461354284 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu….
Clinically Relevant Resistance in Cancer Chemotherapy (Cancer Treatment and Research)
Andersson, Borje, M.D., Ph.D. (Editor)/ Murray, David (Editor)
Lingua: Inglese
Editore: Kluwer Academic Pub 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Revaluation Books, Exeter, Regno UnitoRevaluation Books
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 159,77
EUR 14,48 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 2 disponibili
Hardcover. Condizione: Brand New. 1st edition. 408 pages. 9.25x6.25x1.00 inches. In Stock.
Lingua: Inglese
Editore: Kluwer Academic Publishers 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Rilegato
Da: Kennys Bookstore, Olney, MD, U.S.A.Kennys Bookstore
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 167,05
EUR 9,22 spedizioneSpedito in U.S.A.Quantità: 15 disponibili
Condizione: New. Reviews clinically relevant aspects of the pharmacokinetics of commonly used anticancer agents as well as mechanisms of cellular/experimental resistance to such agents. Editor(s): Andersson, Borje; Murray, David. Series: Cancer Treatment and Research. Num Pages: 400 pages, biography. BIC Classification: MJCL2. C…ategory: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly; (UU) Undergraduate. Dimension: 235 x 155 x 28. Weight in Grams: 777. . 2002. Hardback. . . . . Books ship from the US and Ireland.
Lingua: Inglese
Editore: Springer US, Springer US 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 114,36
EUR 63,05 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias and lymphom…as, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as 'drug resistance'. This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.
Lingua: Inglese
Editore: Springer US, Springer US 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 114,36
EUR 63,05 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. Druck auf Anfrage Neuware - Printed after ordering - The present volume reviews clinically relevant aspects of the pharmacokinetics of commonly used anticancer agents as well as mechanisms of cellular/experimental resistance to such agents. This extends to technological advances that enable high-thr…oughput studies of genetic polymorphisms, which has opened up new avenues to the study of drug resistance and to the individualization of chemotherapy in order to decrease clinical toxicity and optimize treatment results.'This text provides a comprehensive review of the mechanisms of resistance to cancer chemotherapuetic agents. Leading experts discuss molecular and biochemical pathways that influence cytotoxicity. Knowledge of these potential obstacles to therapy will allow for the development of more effective strategies to treat malignant diseases.' Steven T. Rosen, M.D., Series Editor.
Lingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
Da: Mispah books, Redhill, SURRE, Regno UnitoMispah books
Contatta il venditoreVenditore con 4 stelleCondizione: Usato - Come nuovo
EUR 184,98
EUR 28,97 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 1 disponibili
Paperback. Condizione: Like New. Like New. book.
Lingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
- Print on Demand
Da: Brook Bookstore On Demand, Napoli, NA, ItaliaBrook Bookstore On Demand
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 86,24
EUR 6,80 spedizioneSpedito da Italia a U.S.A.Quantità: Più di 20 disponibili
Condizione: new. Questo è un articolo print on demand.
Lingua: Inglese
Editore: Springer US, Springer US Okt 2012 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
- Print on Demand
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 106,99
EUR 23,00 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leuke…mias and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as 'drug resistance'. This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge. 404 pp. Englisch.
Lingua: Inglese
Editore: Springer US, Springer US Okt 2002 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
- Print on Demand
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 106,99
EUR 60,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias… and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as 'drug resistance'. This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 404 pp. Englisch.
Lingua: Inglese
Editore: Springer US, Springer Okt 2012 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
- Print on Demand
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germaniabuchversandmimpf2000
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 106,99
EUR 60,00 spedizioneSpedito da Germania a U.S.A.Quantità: 1 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Over the last several decades, the introduction of new chemotherapeutic drugs and drug combinations has resulted in increased long term remission rates in several important tumor types. These include childhood leukemia, adult leukemias… and lymphomas, as well as testicular and trophoblastic tumors. The addition of high-dose chemotherapy with growth factor and hemopoietic stem cell support has increased clinical remission rates even further. For the majority of patients with some of the more common malignancies, however, palliation (rather than cure) is still the most realistic goal of chemotherapy for metastatic disease. The failure of chemotherapy to cure metastatic cancer is commonly referred to among clinicians as 'drug resistance'. This phenomenon can, however, often be viewed as the survival of malignant cells that resulted from a failure to deliver an effective drug dose to the (cellular) target because of anyone of or combination of a multitude of individual factors. Clinically, this treatment failure is often viewed as the rapid occurrence of resistance at the single cell level. However, in experimental systems, stable drug resistance is usually relatively slow to emerge.Springer-Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 404 pp. Englisch.
Lingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
- Print on Demand
Da: Majestic Books, Hounslow, Regno UnitoMajestic Books
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 173,87
EUR 7,53 spedizioneSpedito da Regno Unito a U.S.A.Quantità: 4 disponibili
Condizione: New. Print on Demand pp. 404.
Lingua: Inglese
Editore: Springer 2012
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
- Print on Demand
Da: Biblios, frankfurt am main, HESSE, GermaniaBiblios
Contatta il venditoreVenditore con 4 stelleCondizione: Nuovo
EUR 172,43
EUR 9,95 spedizioneSpedito da Germania a U.S.A.Quantità: 4 disponibili
Condizione: New. PRINT ON DEMAND pp. 404.
Lingua: Inglese
Editore: Springer US Okt 2002 2002
Serie: Cancer Treatment and Research, Libro 134 di 180. Libro 134 di 180 - Cancer Treatment and Research
- Brossura
- Print on Demand
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, GermaniaBuchWeltWeit Ludwig Meier e.K.
Contatta il venditoreVenditore con 5 stelleCondizione: Nuovo
EUR 197,94
EUR 23,00 spedizioneSpedito da Germania a U.S.A.Quantità: 2 disponibili
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The present volume reviews clinically relevant aspects of the pharmacokinetics of commonly used anticancer agents as well as mechanisms of cellular/experimental resistance to such agents. This extends to technological advances that… enable high-throughput studies of genetic polymorphisms, which has opened up new avenues to the study of drug resistance and to the individualization of chemotherapy in order to decrease clinical toxicity and optimize treatment results.'This text provides a comprehensive review of the mechanisms of resistance to cancer chemotherapuetic agents. Leading experts discuss molecular and biochemical pathways that influence cytotoxicity. Knowledge of these potential obstacles to therapy will allow for the development of more effective strategies to treat malignant diseases.' Steven T. Rosen, M.D., Series Editor 404 pp. Englisch.
